Clinical Trial Update: Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy, dose-ranging and initial safety of Albuterol DPI (A006) in asthma; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol DPI (A006) (Albuterol)

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED